eli lilly and company

News

Texas Sues Eli Lilly Over Bribery Allegations

Eli Lilly to hike UK price of Mounjaro weight-loss, diabetes medicines by 170%

Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line with other European markets, the U.S. drugmaker said on Thursday.

U.S. News & World Report · 1d

Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Its Medications

WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications.

Houston Chronicle · 1d

Texas sues, accusing Eli Lilly of 'bribing' physicians to prescribe Zepbound, Mounjaro and other drugs

Paxton's office said the company supplied free nurses to help care for patients who received its drugs, as well as administrative support services that helped providers process insurance claims.

These Eli Lilly executives have been scooping up stock

MarketWatch on MSN · 1d

These Eli Lilly executives have been scooping up stock after its big drop

Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.

StockStory.org on MSN · 18h

Eli Lilly (LLY) Stock Trades Up, Here Is Why

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after reports of significant insider buying by top executives, including the CEO, sent the stock rebounding from a recent selloff.

Zacks Investment Research on M… · 3d

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this drugmaker have returned -21.

1hon MSN

Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines

Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to ...

5 Must-Read Analyst Questions From Eli Lilly’s Q2 Earnings Call

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

Devdiscourse15m

Eli Lilly's Bold Price Strategy: UK Cost Surge for Mounjaro

Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...

18hon MSN

Jim Cramer on Eli Lilly Stock: “It Just Got Pole-Axed, Laid to Waste”

Last and least, I look at the drug stocks and I can’t believe how awful they really are, with now Eli Lilly last joining the ...

6don MSN

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

Eli Lilly and GSK drive South Korea’s drug licensing activity

South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

3don MSN

Eli Lilly (LLY) Announced Positive Results From its Phase 3 ATTAIN-1 Trial of Orforglipron

Eli Lilly and Company (NYSE: LLY) is one of the Good Stocks to Invest in Now. On August 7, Eli Lilly and Company (NYSE:LLY) ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results